CN102366484B - Pharmaceutical composition for treating herpes zoster and preparation method thereof - Google Patents
Pharmaceutical composition for treating herpes zoster and preparation method thereof Download PDFInfo
- Publication number
- CN102366484B CN102366484B CN2011103081859A CN201110308185A CN102366484B CN 102366484 B CN102366484 B CN 102366484B CN 2011103081859 A CN2011103081859 A CN 2011103081859A CN 201110308185 A CN201110308185 A CN 201110308185A CN 102366484 B CN102366484 B CN 102366484B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- herpes zoster
- pharmaceutical composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 53
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 39
- 235000011837 pasties Nutrition 0.000 claims abstract description 4
- 241001071795 Gentiana Species 0.000 claims abstract description 3
- 229940126701 oral medication Drugs 0.000 claims description 33
- 241000628997 Flos Species 0.000 claims description 15
- 241000131808 Scolopendra Species 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000222640 Polyporus Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 12
- 230000036407 pain Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 208000004880 Polyuria Diseases 0.000 abstract description 6
- 230000035619 diuresis Effects 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 5
- 239000002674 ointment Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 241001544357 Eurya chinensis Species 0.000 abstract 2
- 241000245665 Taraxacum Species 0.000 abstract 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 14
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 230000035876 healing Effects 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 10
- 201000006082 Chickenpox Diseases 0.000 description 9
- 206010046980 Varicella Diseases 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000035415 Reinfection Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001570521 Lonicera periclymenum Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 230000035929 gnawing Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pharmaceutical composition for treating herpes zoster and a preparation method thereof. The pharmaceutical composition for treating herpes zoster comprises an oral medicine and an external medicine, wherein the oral medicine comprises honeysuckle flower, taraxacum, Plantain seed, fiveleaf akebia, radix rehmanniae, radix bupleuri, gentian, isatis leaf, Eurya chinensis root and the like; and the external medicine comprises Eurya chinensis root, white alum, taraxacum, centipede and the like. The preparation method is implemented by decocting with water to obtain a pasty ointment. The pharmaceutical composition has the main functions of clearing away the liver-fire and removing dampness by diuresis, and can completely cure herpes zoster without relapse; the healed patient does not have the pain symptom; and thus, the pharmaceutical composition can treat both the symptoms and root causes of herpes zoster, thereby achieving the goal of complete cure and obvious effect. The cure rate is up to higher than 90%. The preparation method is simple and easy to implement.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, specifically a kind of pharmaceutical composition and preparation method for the treatment of herpes zoster, belong to the field of Chinese medicines.
Background technology
Herpes zoster (Herpes Zoster) is the acute inflammation dermatoses that is caused by varicella zoster virus, and the traditional Chinese medical science is called " skirt-roof HUOLONG ", " herpes zoster ".Among the people being commonly called as " herpes zoster ", " herpes zoster ".Be commonly referred to be because liver-kidney irritation, retention of damp-heat in the interior cause, the morbidity main feature is for bunch catchmenting bubble, along the side peripheral nerve do zonal distribution of trooping, often with obvious neuralgia.The people is unique host of varicella zoster virus, and virus enters blood through respiratory mucosa and forms viremia, chickenpox occurs or be inapparent infection, and virus can be hidden in spinal cord posterior root ganglion or ganglia sensorialia nervi encephalici for a long time later on.When body is subject to certain stimulation (as wound, fatigue, malignant tumor or weak etc. after being ill) when causing Abwehrkraft des Koepers to descend, latent virus is activated, arrange in regional skin along descending this nerve of arrival of sensory nerve axon and copy the generation vesicle, getting involved simultaneously, nerve is inflamed, necrosis, produces neuralgia.
Primary disease causes primary infection in the human body (as the child) of nothing or low immunity, pathogen VZV virus mainly enters blood through respiratory mucosa and forms viremia, i.e. chickenpox.After the chickenpox transference cure, the virus that infects is to hide the form long-term existence in the neurocyte of spinal nerves or cranial nerve, after being activated by some factor, virus is from one or several neuroganglions edge corresponding sensory nerves on every side arrival skins, breed rapidly also disorganize, cell at teleneuron, make it inflammation, hemorrhage, dead and fall ill, cause recurrent infection, i.e. herpes zoster.After chickenpox was suffered from primary infection, a minority can namely suffer from herpes zoster by recurrent infection; Most people carries virus recurrent infection not all the life.Patients with Herpes Zoster produces antibody after clinical symptom disappearance, lifetime immunity has some patients were and transfers post herpetic neuralgia to.
The treatment of herpes zoster is mainly pain relieving usually and prevent that the secondary antibacterial from infecting.For example add the face powder external with 1% Camphora, 5% sulfur Calamine Lotion, 0.5% neomycin ointment, the injection vitamin B
12Perhaps inject transfer factor or gamma globulin.Yet these common therapy Chang Buneng are completely cured, even the herpes remission, also still gnawing pains take no rest.
Summary of the invention
In order to address the above problem, the present invention has designed a kind of pharmaceutical composition and preparation method for the treatment of herpes zoster, this pharmaceutical composition is take clearing away liver-fire, dampness removing warm as main, can cure herpes zoster fully, and do not recur, after healing, again without the pain symptom, this preparation method is simple, easy goes, operational approach.
Technical scheme of the present invention is:
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion:
Flos Lonicerae 1-4 part, Herba Taraxaci 20-40 part, Semen Plantaginis 4-8 part, Caulis Akebiae 0.8-1.2 part, Radix Rehmanniae 2-6 part, Radix Bupleuri 1.2-2.5 part, Radix Gentianae 2-4 part, Folium Isatidis 2-4 part, Radix Euryae Chinensis root 8-12 part;
Described external used medicine is by the ingredients of following weight portion:
Radix Euryae Chinensis root 4-7 part, Alumen 0.5-1.5 part, Herba Taraxaci 8-12 part, Scolopendra 0.3-0.8 part.
Preferably, described oral drugs are by the ingredients of following weight portion:
3 parts of Flos Loniceraes, 30 parts of Herba Taraxacis, 6 parts of Semen Plantaginiss, 1 part of Caulis Akebiae, 4 parts, the Radix Rehmanniae, 2 parts of Radix Bupleuri, 3 parts of Radix Gentianaes, 3 parts of Folium Isatidiss, 10 parts of Radix Euryae Chinensis roots;
Described external used medicine is by the ingredients of following weight portion:
5 parts of Radix Euryae Chinensis roots, 1 part of Alumen, 10 parts of Herba Taraxacis, 0.5 part of Scolopendra.
Further, described oral drugs also comprise Rhizoma Coptidis 2-4 part, and Radix Paeoniae Rubra 4-8 part is wherein preferred: 3 parts of Rhizoma Coptidis, 6 parts of Radix Paeoniae Rubra; Be applicable to thermogravimetric, pain symptom.
Further, described oral drugs also comprise Rhizoma Atractylodis 2-4 part, Poria 8-12 part and Polyporus 25-35 part, and are wherein preferred: 30 parts of 3 parts of Rhizoma Atractylodis, 10 parts, Poria and Polyporus; Be applicable to the weight in wet base symptom.
The preparation and application of above-mentioned oral drugs is: after above-mentioned oral drugs weighing, and decocting, oral, 3 times on the one;
The preparation and application of above-mentioned external used medicine is: after above-mentioned external used medicine weighing, grind into powder after wrapping up in yellow paper bag, is lighted, and the ash after then burning is last with Oleum sesami furnishing pasty state, external application, 3-5 time on the one.Yellow paper is toilet paper, the paper of making for raw material with Caulis et Folium Oryzae etc.
Flos Lonicerae is Caprifoliaceae woodbine Radix Ophiopogonis and congener dry flower or the first flower of opening of band.The sweet cold fragrance of heat-clearing and toxic substances removing, property, clearing away heat with drugs sweet in flavor and cold in nature can dispelling wind-heat, and also kind removing summer-heat blood poison, be used for various febrile diseases, and as fever of the body, dermexanthesis, send out the cards such as speckle, pyretic toxicity carbuncle sore, laryngopharynx swelling and pain, all effect is remarkable;
The Dandelion Compositae belongs to herbaceos perennial, and the flat sweet and slightly bitter taste of property has heat-clearing and toxic substances removing, dispersing swelling and dissipating binds and galgctogogue action, and is very effective to the treatment mastitis, can oral, external application.In addition, Herba Taraxaci also has the effects such as diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting; Semen Plantaginis, sweet in flavor and cold in property, enter kidney, bladder, liver, lung meridian, function relieving stranguria by diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, removing heat-phlegm;
Caulis Akebiae, nature and flavor are bitter, cool, pathogenic fire purging row water, promoting blood circulation cures mainly hot urination, stranguria with turbid discharge, edema, irritable feverish sensation in the chest, sore throat pharyngalgia, inflexible pain all over, women's amenorrhea, galactostasis;
The Radix Rehmanniae, the another name Radix Rehmanniae, sweet in the mouth, hardship, cold in nature.GUIXIN, liver, lung meridian; Clearing away heat and promoting production of body fluid, removing heat from blood, hemostasis, yin nourishing is used for consumption of YIN caused by febrile disease, and the crimson tongue excessive thirst is sent out the speckle dermexanthesis, yin asthenia generating intrinsic heat, the hectic fever due to YIN-deficiency consumptive fever is spitted blood, epistaxis, laryngopharynx swelling and pain;
Radix Bupleuri, nature and flavor are bitter, be slightly cold, and return Liver Channel, gallbladder meridian, evacuate bring down a fever, the yang invigorating soothing liver-QI, cure mainly: cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, the uterus comes off, menoxenia;
Radix Gentianae, bitter in the mouth, cold in nature is returned liver, gallbladder meridian, has the effect of heat clearing away, eliminating pathogen in the liver, arresting convulsion, cures mainly cold and heat between bone, frightened pathogenic factor gas, and the wound absolutely that continues is decided the five internal organs, the parasite killing poison;
Folium Isatidis, bitter in the mouth, cold in nature enters liver, the heart, stomach warp, is mainly used in pyretic toxicity and sends out the diseases such as speckle, erysipelas, laryngopharynx swelling and pain, aphtha of the mouth and tongue, sore and toxic;
The Radix Euryae Chinensis root, mildly bitter flavor, cool in nature is mainly used in the heat-clearing and toxic substances removing sore;
Rhizoma Coptidis, bitter, cold, GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel, heat clearing and damp drying, eliminating fire and detoxication.Be used for damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, toothache is quenched one's thirst, the carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated;
Radix Paeoniae Rubra, bitter in the mouth, cold nature is returned Liver Channel, has the function of clearing away heat and cooling blood, eliminating stasis to stop pain, and multiplex fever of the body in the epidemic febrile disease pathogenic heat attacking blood system in febrile diseases is hemorrhage, conjunctival congestion and swelling pain, carbuncle sore tumefacting virus;
Rhizoma Atractylodis, hot, bitter, temperature is returned spleen, stomach, Liver Channel, and is drying damp and strengthening spleen, and expelling wind and cold makes eye bright, and is used for distension and fullness in the abdomen, the edema of having loose bowels, beriberi flaccidity of feet with lamenness, rheumatic arthralgia, anemofrigid cold, nyctalopia;
Poria, sweet in the mouth, light, property are flat, be used as medicine have promoting diuresis to eliminate damp pathogen, the function of strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming;
Polyporus, sweet in the mouth, light, flat is returned kidney, urinary bladder channel, and promoting diuresis to eliminate damp pathogen is controlled dysuria, edema, is had loose bowels, stranguria with turbid discharge, leukorrhagia;
Alumen, sour and astringent, cold, poisonous, return lung, spleen, liver, large intestine, urinary bladder channel, expectorant, dampness, antidiarrheal, hemostasis, detoxifcation, parasite killing;
Herba Taraxaci, sweet in the mouth, little hardship, cold, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds;
Scolopendra, salty, hot, temperature.Poisonous.Return liver, spleen, lung meridian, anticancer, the relieving spasm by calming endogenous wind of relieving internal heat, move back inflammation and control skin ulcer;
Said medicine Flos Lonicerae, Herba Taraxaci, Semen Plantaginis, Caulis Akebiae, the Radix Rehmanniae, Radix Bupleuri, Radix Gentianae, Folium Isatidis, Radix Euryae Chinensis root all have the effect of heat-clearing and toxic substances removing, can clearing away liver-fire, dampness removing heat, the disease oral by decocting, that solution liver-kidney irritation, retention of damp-heat in the interior cause reaches the purpose of effecting a permanent cure; Other Radix Euryae Chinensis root, Alumen, Herba Taraxaci, Scolopendra can be sterilized, its heat-clearing and toxic substances removing sore effect of the heat of dispelling, especially Radix Euryae Chinensis root is obvious, are used for external application, eliminate the surface symptoms of herpes zoster, reach the purpose of taking stopgap measures.By said medicine, herpes zoster is carried out treating both the principal and secondary aspects of a disease, thereby reach the purpose of curing fully, effect is remarkable.
The invention has the advantages that: pharmaceutical composition is take clearing away liver-fire, dampness removing warm as main, can cure herpes zoster fully, and do not recur, after healing again without the pain symptom, to herpes zoster double the effecting a permanent cure of taking stopgap measures, thereby reach the purpose of curing fully, effect is remarkable, cure rate reaches more than 90%, and preparation method is simple.
The specific embodiment
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein only is used for description and interpretation the present invention, is not intended to limit the present invention.
Embodiment 1
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 1g, Herba Taraxaci 20g, Semen Plantaginis 4g, Caulis Akebiae 0.8g, Radix Rehmanniae 2g, Radix Bupleuri 1.2g, Radix Gentianae 2g, Folium Isatidis 2g, Radix Euryae Chinensis root 8g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 4g, Alumen 0.5g, Herba Taraxaci 8g, Scolopendra 0.3g.
The preparation and application of above-mentioned oral drugs is: after above-mentioned oral drugs weighing, and decocting, oral, 3 times on the one;
The preparation and application of above-mentioned external used medicine is: after above-mentioned external used medicine weighing, grind into powder after wrapping up in yellow paper bag, is lighted, and the ash after then burning is last with Oleum sesami furnishing pasty state, external application, 3-5 time on the one.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 90 examples, effective 5 examples, invalid 5 examples, cure rate reaches 90%.
The patient: Cao, the address: Xi Guan village, Gaomi City, Shandong, suffer from herpes zoster in JIUYUE, 2010; Adopt pharmaceutical methods of the present invention, treat 10 days transference cures, cure fully, without recurrence.Check before treatment and find to have varicella zoster virus, check without the chickenpox varicella zoster virus after treatment.
Embodiment 2
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 4g, Herba Taraxaci 40g, Semen Plantaginis 8g, Caulis Akebiae 1.2g, Radix Rehmanniae 6g, Radix Bupleuri 2.5g, Radix Gentianae 4g, Folium Isatidis 4g, Radix Euryae Chinensis root 12g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 7g, Alumen 1.5g, Herba Taraxaci 12g, Scolopendra 0.8g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 91 examples, effective 5 examples, invalid 4 examples, cure rate reaches 92%.
The patient: Zhang, the address: Xi Guan village, Gaomi City, Shandong, suffer from herpes zoster in April, 2010; Adopt pharmaceutical methods of the present invention, treat 9 days transference cures, cure fully, without recurrence.Check before treatment and find to have varicella zoster virus, check without the chickenpox varicella zoster virus after treatment.
Embodiment 3
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 3g, Herba Taraxaci 30g, Semen Plantaginis 6g, Caulis Akebiae 1g, Radix Rehmanniae 4g, Radix Bupleuri 2g, Radix Gentianae 3g, Folium Isatidis 3g, Radix Euryae Chinensis root 10g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 5g, Alumen 1g, Herba Taraxaci 10g, Scolopendra 0.5g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 93 examples, effective 4 examples, invalid 3 examples, cure rate reaches 93%.
The patient: Tang, the address: Shen Jiatun village, Gaomi City, Shandong Province, suffer from herpes zoster in February, 2011; Adopt pharmaceutical methods of the present invention, treat 6 days transference cures, cure fully, without recurrence.Check before treatment and find to have varicella zoster virus, check without the chickenpox varicella zoster virus after treatment.
Embodiment 4
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 1g, Herba Taraxaci 20g, Semen Plantaginis 4g, Caulis Akebiae 0.8g, Radix Rehmanniae 2g, Radix Bupleuri 1.2g, Radix Gentianae 2g, Folium Isatidis 2g, Radix Euryae Chinensis root 8g, Rhizoma Coptidis 2g, Radix Paeoniae Rubra 4g; Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 4g, Alumen 0.5g, Herba Taraxaci 8g, Scolopendra 0.3g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 94 examples, effective 3 examples, invalid 3 examples, cure rate reaches 94%.
Embodiment 5
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 4g, Herba Taraxaci 40g, Semen Plantaginis 8g, Caulis Akebiae 1.2g, Radix Rehmanniae 6g, Radix Bupleuri 2.5g, Radix Gentianae 4g, Folium Isatidis 4g, Radix Euryae Chinensis root 12g, Rhizoma Coptidis 4g, Radix Paeoniae Rubra 8g; Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 7g, Alumen 1.5g, Herba Taraxaci 12g, Scolopendra 0.8g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 94 examples, effective 4 examples, invalid 2 examples, cure rate reaches 94%.
Embodiment 6
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 3g, Herba Taraxaci 30g, Semen Plantaginis 6g, Caulis Akebiae 1g, Radix Rehmanniae 4g, Radix Bupleuri 2g, Radix Gentianae 3g, Folium Isatidis 3g, Radix Euryae Chinensis root 10g, Rhizoma Coptidis 3g, Radix Paeoniae Rubra 6g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 5g, Alumen 1g, Herba Taraxaci 10g, Scolopendra 0.5g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 95 examples, effective 4 examples, invalid 1 example, cure rate reaches 95%.
The patient: Hu, the address: broad three villages, Gaomi City, Shandong, suffer from the thermogravimetric herpes zoster in November, 2010; Adopt pharmaceutical methods of the present invention, treat 5 days transference cures, cure fully, without recurrence.Check before treatment and find to have varicella zoster virus, check without the chickenpox varicella zoster virus after treatment.
Embodiment 7
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 1g, Herba Taraxaci 20g, Semen Plantaginis 4g, Caulis Akebiae 0.8g, Radix Rehmanniae 2g, Radix Bupleuri 1.2g, Radix Gentianae 2g, Folium Isatidis 2g, Radix Euryae Chinensis root 8g, Rhizoma Atractylodis 2g, Poria 8g and Polyporus 25g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 4g, Alumen 0.5g, Herba Taraxaci 8g, Scolopendra 0.3g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 94 examples, effective 4 examples, invalid 2 examples, cure rate reaches 94%.
Embodiment 8
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 4g, Herba Taraxaci 40g, Semen Plantaginis 8g, Caulis Akebiae 1.2g, Radix Rehmanniae 6g, Radix Bupleuri 2.5g, Radix Gentianae 4g, Folium Isatidis 4g, Radix Euryae Chinensis root 12g, Rhizoma Atractylodis 4g, Poria 12g and Polyporus 35g;
Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 7g, Alumen 1.5g, Herba Taraxaci 12g, Scolopendra 0.8g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 95 examples, effective 4 examples, invalid 1 example, cure rate reaches 95%.
Embodiment 9
A kind of pharmaceutical composition for the treatment of herpes zoster comprises oral drugs and external used medicine;
Described oral drugs are by the ingredients of following weight portion: Flos Lonicerae 3g, Herba Taraxaci 30g, Semen Plantaginis 6g, Caulis Akebiae 1g, Radix Rehmanniae 4g, Radix Bupleuri 2g, Radix Gentianae 3g, Folium Isatidis 3g, Radix Euryae Chinensis root 10g, Rhizoma Atractylodis 3g, Poria 10g and Polyporus 30g; Described external used medicine is by the ingredients of following weight portion: Radix Euryae Chinensis root 5g, Alumen 1g, Herba Taraxaci 10g, Scolopendra 0.5g.
Preparation and application is with embodiment 1.
The treatment case: adopt the patients that the method for pharmaceutical composition of the present invention is suffered from herpes zoster to 100 examples to treat, under the identical condition of other condition, treat 14 days, healing 96 examples, effective 3 examples, invalid 1 example, cure rate reaches 96%.
The patient: Cao, the address: the hollow village of Chaoyang street, Gaomi City, Shandong Qiu family, suffer from the weight in wet base herpes zoster in JIUYUE, 2010; Adopt pharmaceutical methods of the present invention, treat 4 days transference cures, cure fully, without recurrence.Check before treatment and find to have varicella zoster virus, check without the chickenpox varicella zoster virus after treatment.
It should be noted that at last: the above only is the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment, the present invention is had been described in detail, for a person skilled in the art, it still can be modified to the technical scheme that aforementioned each embodiment puts down in writing, and perhaps part technical characterictic wherein is equal to replacement.Within the spirit and principles in the present invention all, any modification of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (7)
1. a pharmaceutical composition for the treatment of herpes zoster, is characterized in that: comprise oral drugs and external used medicine;
Described oral drugs comprise the raw material of following weight portion:
Flos Lonicerae 1-4 part, Herba Taraxaci 20-40 part, Semen Plantaginis 4-8 part, Caulis Akebiae 0.8-1.2 part, Radix Rehmanniae 2-6 part, Radix Bupleuri 1.2-2.5 part, Radix Gentianae 2-4 part, Folium Isatidis 2-4 part, Radix Euryae Chinensis root 8-12 part;
Described external used medicine comprises the raw material of following weight portion:
Radix Euryae Chinensis root 4-7 part, Alumen 0.5-1.5 part, Herba Taraxaci 8-12 part, Scolopendra 0.3-0.8 part.
2. a kind of pharmaceutical composition for the treatment of herpes zoster according to claim 1, is characterized in that,
Described oral drugs comprise the raw material of following weight portion:
3 parts of Flos Loniceraes, 30 parts of Herba Taraxacis, 6 parts of Semen Plantaginiss, 1 part of Caulis Akebiae, 4 parts, the Radix Rehmanniae, 2 parts of Radix Bupleuri, 3 parts of Radix Gentianaes, 3 parts of Folium Isatidiss, 10 parts of Radix Euryae Chinensis roots;
Described external used medicine comprises the raw material of following weight portion:
5 parts of Radix Euryae Chinensis roots, 1 part of Alumen, 10 parts of Herba Taraxacis, 0.5 part of Scolopendra.
3. a kind of pharmaceutical composition for the treatment of herpes zoster according to claim 1 is characterized in that:
Described oral drugs also comprise Rhizoma Coptidis 2-4 part, Radix Paeoniae Rubra 4-8 part.
4. a kind of pharmaceutical composition for the treatment of herpes zoster according to claim 1 is characterized in that:
Described external used medicine also comprises Rhizoma Atractylodis 2-4 part, Poria 8-12 part and Polyporus 25-35 part.
5. a kind of pharmaceutical composition for the treatment of herpes zoster according to claim 3, is characterized in that: 3 parts of described Rhizoma Coptidis, 6 parts of Radix Paeoniae Rubra.
6. a kind of pharmaceutical composition for the treatment of herpes zoster according to claim 4, is characterized in that: 3 parts of described Rhizoma Atractylodis, 10 parts, Poria, 30 parts of Polyporus.
7. a kind of preparation method for the treatment of the pharmaceutical composition of herpes zoster as described in any one in claim 1-6 is characterized in that:
The preparation method of above-mentioned oral drugs is: after above-mentioned oral drugs weighing, and decocting;
The preparation method of above-mentioned external used medicine is: after above-mentioned external used medicine weighing, grind into powder after wrapping up in yellow paper bag, is lighted, and the ash after then burning is last with Oleum sesami furnishing pasty state.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103081859A CN102366484B (en) | 2011-10-12 | 2011-10-12 | Pharmaceutical composition for treating herpes zoster and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103081859A CN102366484B (en) | 2011-10-12 | 2011-10-12 | Pharmaceutical composition for treating herpes zoster and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102366484A CN102366484A (en) | 2012-03-07 |
| CN102366484B true CN102366484B (en) | 2013-06-26 |
Family
ID=45759104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103081859A Expired - Fee Related CN102366484B (en) | 2011-10-12 | 2011-10-12 | Pharmaceutical composition for treating herpes zoster and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102366484B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031199A (en) * | 2015-09-07 | 2015-11-11 | 王俊喜 | Traditional Chinese medicine for treating herpes zoster |
| CN106491919A (en) * | 2016-12-25 | 2017-03-15 | 闫大伟 | A kind of Chinese medicine for treating herpes labialis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1836715A (en) * | 2005-03-26 | 2006-09-27 | 李有凤 | External use medicine for quickly treating herpes zoster |
| CN101422542A (en) * | 2008-11-27 | 2009-05-06 | 冯伟民 | Medicine for treating herpes zoster |
-
2011
- 2011-10-12 CN CN2011103081859A patent/CN102366484B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1836715A (en) * | 2005-03-26 | 2006-09-27 | 李有凤 | External use medicine for quickly treating herpes zoster |
| CN101422542A (en) * | 2008-11-27 | 2009-05-06 | 冯伟民 | Medicine for treating herpes zoster |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102366484A (en) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104799115A (en) | Chicken compound feed and preparation method thereof | |
| CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
| US7005146B2 (en) | Complex prescription of chinese medicine for the treatment of extensive cancer | |
| CN103127410B (en) | Traditional Chinese medicine composition used for treating oral ulcer | |
| CN103169883B (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN102579807B (en) | Chinese medicine composition for treating dental ulcer | |
| CN102366484B (en) | Pharmaceutical composition for treating herpes zoster and preparation method thereof | |
| CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
| CN103028040B (en) | Traditional Chinese medicine composition for treating infantile chronic nasosinusitis and preparation method of traditional Chinese medicine composition | |
| CN102657789B (en) | Chinese medicinal preparation for puppy infectious hepatitis | |
| CN103028041B (en) | Traditional Chinese medicine composition for treating acute nasosinusitis of children and preparation method of traditional Chinese medicine composition | |
| CN101985030A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN104474308A (en) | Traditional Chinese medicine composition for treating acute cystitis | |
| CN103751656A (en) | Traditional Chinese medicine decoction for treating turbid urea disease | |
| CN103536671A (en) | Drug for treating ischialgia | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
| CN101716307A (en) | Traditional Chinese medicine for treating AIDS | |
| CN105727036A (en) | Traditional Chinese medicinal composition used for treating marek's disease of chicken and preparation method thereof | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN105363006A (en) | Traditional Chinese medicine ointment for nursing care and treatment of infantile febrile convulsion | |
| CN104644868A (en) | Traditional Chinese medicine composition for treating arthritis caused by rheumatic fever and preparation method of traditional Chinese medicine composition | |
| CN104758830A (en) | Traditional Chinese medicine composition for treating bone disease and skin injury and preparation method of traditional Chinese medicine composition | |
| CN104547190A (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN104721786A (en) | Traditional Chinese medicine preparation for treating intrahepatic cholestasis of pregnancy and preparation method of traditional Chinese medicine preparation | |
| CN104258223A (en) | Traditional Chinese medicine for treating pulmonary tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130626 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |